Chicago Equity Partners’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-16,270
Closed -$956K – 873
2018
Q1
$956K Sell
16,270
-585
-3% -$32.8K 0.03% 513
2017
Q4
$922K Sell
16,855
-25
-0.1% -$1.3K 0.03% 518
2017
Q3
$798K Buy
+16,880
New +$795K 0.03% 552
2016
Q4
– Sell
-5,110
Closed -$219K – 776
2016
Q3
$219K Buy
+5,110
New +$228K 0.01% 686
2016
Q2
– Sell
-40,620
Closed -$1.69M – 669
2016
Q1
$1.69M Buy
40,620
+430
+1% +$16.9K 0.05% 282
2015
Q4
$1.58M Sell
40,190
-220
-0.5% -$8.22K 0.04% 295
2015
Q3
$1.36M Buy
+40,410
New +$1.44M 0.04% 313

Other funds holding OFIX

Chicago Equity Partners's OFIX Position: Q2 2018 in Review

Chicago Equity Partners sold out of Orthofix Medical (OFIX) in Q2 2018, closing a stake of 16,270 shares — an estimated $956K sold.

Chicago Equity Partners first reported a position in OFIX in Q3 2015 and held it in 7 quarters. The position peaked at $1.69M in Q1 2016. 163 funds tracked by Wall St. Rank hold OFIX as of Q2 2018.

  • Chicago Equity Partners reported no remaining Orthofix Medical position as of Q2 2018 after selling out during the quarter.
  • Chicago Equity Partners sold 16,270 Orthofix Medical shares in Q2 2018, an estimated $956K.
  • Chicago Equity Partners first reported a position in Orthofix Medical in Q3 2015 and held it in 7 quarters.
  • Chicago Equity Partners's Orthofix Medical position peaked at $1.69M in Q1 2016.
  • 163 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2018.

Based on Chicago Equity Partners's 13F filing for Q2 2018, filed 10 Aug 2018.